Raymond James & Associates’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$201K	Buy	118,197 +8,430	+8%	+$13.8K	﹤0.01%	3637
2024 Q2	$150K	Buy	109,767 +23,161	+27%	+$46.8K	﹤0.01%	3666
2024 Q1	$325K	Buy	86,606 +19,213	+29%	+$112K	﹤0.01%	3333
2023 Q4	$661K	Buy	67,393 +12,373	+22%	+$101K	﹤0.01%	2781
2023 Q3	$459K	Sell	55,020 -18,726	-25%	-$214K	﹤0.01%	2951
2023 Q2	$981K	Sell	73,746 -4,636	-6%	-$56.3K	﹤0.01%	2488
2023 Q1	$908K	Sell	78,382 -7,078	-8%	-$70.4K	﹤0.01%	2510
2022 Q4	$699K	Sell	85,460 -9,630	-10%	-$83K	﹤0.01%	2651
2022 Q3	$552K	Buy	95,090 +1,365	+1%	+$7.83K	﹤0.01%	2796
2022 Q2	$414K	Sell	93,725 -17,961	-16%	-$109K	﹤0.01%	3026
2022 Q1	$1.02M	Buy	111,686 +813	+0.7%	+$9.36K	﹤0.01%	2583
2021 Q4	$2.27M	Sell	110,873 -22,300	-17%	-$538K	﹤0.01%	2089
2021 Q3	$3.4M	Buy	133,173 +3,214	+2%	+$95.2K	﹤0.01%	1743
2021 Q2	$4.54M	Sell	129,959 -19,610	-13%	-$570K	﹤0.01%	1549
2021 Q1	$4.98M	Buy	149,569 +46,782	+46%	+$1.64M	0.01%	1427
2020 Q4	$2.67M	Sell	102,787 -20,018	-16%	-$340K	﹤0.01%	1718
2020 Q3	$1.21M	Buy	122,805 +74,394	+154%	+$428K	﹤0.01%	2063
2020 Q2	$167K	Buy	+48,411	New	+$165K	﹤0.01%	3180
2019 Q4	–	Sell	-12,000	Closed	-$62K	–	3728
2019 Q3	$62K	Hold	12,000	–	–	﹤0.01%	3451
2019 Q2	$73K	Hold	12,000	–	–	﹤0.01%	3451
2019 Q1	$87K	Buy	+12,000	New	+$86.8K	﹤0.01%	3416